Diels-Alder Hydrogels and Micelles for Ocular Drug Delivery: From Design to Preclinical Evaluation

Blessing Ilochonwu

What was your PhD about? 

"My doctoral research focused on advancing the treatment of retinal eye diseases. The primary objective of my thesis was to explore enhanced methods for delivering medications to the eye, eliminating the need for frequent injections. The study centered on the innovative development of materials, such as hydrogels and micelles, engineered to either extend the duration of drug effectiveness in the eye or penetrate deeper into the retina. The outcomes of this research provided new insights into drug delivery to the back of the eye."

What is your fondest memory of your time at RMU?  

"I particularly enjoyed being part of an International Training Network program called Ocuther. This network not only facilitated travel for discussions and collaborative experiments with experts in eye drug delivery across Europe but also enriched my professional network. While these experiences were exhilarating, what made them truly special was the sense of returning to what felt like home in Utrecht鈥攅very moment shared with colleagues and friends from different parts of the world, whether studying or working at UIPS departments and the Science Park campus. These memories are all unforgettable times that I will always hold dear."  

What are you going to do next?  

"I have recently taken on a role as a postdoctoral scientist at a pharmaceutical company, where I continue to explore innovative approaches to treat eye diseases. Looking ahead, I aspire to bridge the gap between industry and academia, collaborating with both to advance the development of materials that seamlessly transition from laboratory batches to real-world applications. My goal is to contribute to improving patients' quality of life by bringing together the expertise and resources from both sectors."